These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20507312)

  • 1. All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.
    Singh AT; Evens AM; Anderson RJ; Beckstead JA; Sankar N; Sassano A; Bhalla S; Yang S; Platanias LC; Forte TM; Ryan RO; Gordon LI
    Br J Haematol; 2010 Jul; 150(2):158-69. PubMed ID: 20507312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Nanoscale Delivery Particles Encapsulated with Anticancer Drugs, All-trans Retinoic Acid or Curcumin, Enhance Apoptosis in Lymphoma Cells Predominantly Expressing CD20 Antigen.
    Stauffer RG; Mohammad M; Singh AT
    Anticancer Res; 2015 Dec; 35(12):6425-9. PubMed ID: 26637852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.
    Singh AT; Ghosh M; Forte TM; Ryan RO; Gordon LI
    Leuk Lymphoma; 2011 Aug; 52(8):1537-43. PubMed ID: 21699455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
    Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
    Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
    Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
    Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis.
    Chen PH; Shih CM; Chang WC; Cheng CH; Lin CW; Ho KH; Su PC; Chen KC
    J Neurochem; 2014 Dec; 131(6):731-42. PubMed ID: 25040912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
    Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
    Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion.
    Ertesvag A; Engedal N; Naderi S; Blomhoff HK
    J Immunol; 2002 Nov; 169(10):5555-63. PubMed ID: 12421932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro.
    Chen S; Yang Y; Xu J; Su L; Wang W
    Br J Nutr; 2014 May; 111(9):1586-93. PubMed ID: 24495389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.
    Liu S; Wu Q; Chen ZM; Su WJ
    World J Gastroenterol; 2001 Oct; 7(5):662-6. PubMed ID: 11819850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
    Mehta K; McQueen T; Manshouri T; Andreeff M; Collins S; Albitar M
    Blood; 1997 May; 89(10):3607-14. PubMed ID: 9160665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
    Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
    Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
    Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
    Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral activity of 13-demethyl or 13-substituted analogues of all-trans retinoic acid and 9-cis retinoic acid in the human myeloid leukemia cell line HL-60.
    Mizuguchi Y; Wada A; Nakagawa K; Ito M; Okano T
    Biol Pharm Bull; 2006 Sep; 29(9):1803-9. PubMed ID: 16946489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
    Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.